These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30192930)

  • 1. Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis.
    Dahl Aarvik M; Sandven I; Dondo TB; Gale CP; Ruddox V; Munkhaugen J; Atar D; Otterstad JE
    Eur Heart J Cardiovasc Pharmacother; 2019 Jan; 5(1):12-20. PubMed ID: 30192930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Oral Beta-Blocker Therapy Improve Long-Term Survival in ST-Segment Elevation Myocardial Infarction With Preserved Systolic Function? A Meta-Analysis.
    Misumida N; Harjai K; Kernis S; Kanei Y
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):280-5. PubMed ID: 26424094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Long-Term Oral Beta-Blocker Therapy in Patients Who Underwent Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction With Preserved Left Ventricular Ejection Fraction: A Systematic Review and Meta-analysis.
    Maqsood MH; Alam M; Atar D; Birnbaum Y
    J Cardiovasc Pharmacol; 2021 Jan; 77(1):87-93. PubMed ID: 33136764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality: a Swedish nationwide observational study.
    Mohammad MA; Andell P; Koul S; Desta L; Jernberg T; Omerovic E; Spaak J; Fröbert O; Jensen J; Engstrøm T; Hofman-Bang C; Persson H; Erlinge D
    EuroIntervention; 2017 Jun; 13(2):e210-e218. PubMed ID: 28242589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristics.
    Kristensen AMD; Munkhaugen J; Halvorsen S; Olsen MH; Bakken A; Sehested TSG; Ruddox V; Lange T; Fagerland MW; Torp-Pedersen C; Prescott E; Atar D
    Eur Heart J Cardiovasc Pharmacother; 2024 May; 10(3):175-183. PubMed ID: 38017624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Events After Discontinuation of β-Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction: A Cohort Study on the French Healthcare Databases.
    Neumann A; Maura G; Weill A; Alla F; Danchin N
    Circ Cardiovasc Qual Outcomes; 2018 Apr; 11(4):e004356. PubMed ID: 29653999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction.
    Hioki H; Motoki H; Izawa A; Kashima Y; Miura T; Ebisawa S; Tomita T; Miyashita Y; Koyama J; Ikeda U
    Heart Vessels; 2016 May; 31(5):687-93. PubMed ID: 25863805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
    Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
    Cochrane Database Syst Rev; 2014 Sep; (9):CD004476. PubMed ID: 25233038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial.
    Kristensen AMD; Bovin A; Zwisler AD; Cerquira C; Torp-Pedersen C; Bøtker HE; Gustafsson I; Veien KT; Thomsen KK; Olsen MH; Larsen ML; Nielsen OW; Hildebrandt P; Foghmar S; Jensen SE; Lange T; Sehested T; Jernberg T; Atar D; Ibanez B; Prescott E
    Trials; 2020 May; 21(1):415. PubMed ID: 32446298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical outcomes in patients with cardiogenic shock according to left ventricular function: The French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) programme.
    Aissaoui N; Riant E; Lefèvre G; Delmas C; Bonello L; Henry P; Bonnefoy E; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E;
    Arch Cardiovasc Dis; 2018 Nov; 111(11):678-685. PubMed ID: 29290598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postconditioning in ST-elevation myocardial infarction: a systematic review, critical appraisal, and meta-analysis of randomized clinical trials.
    Abdelnoor M; Sandven I; Limalanathan S; Eritsland J
    Vasc Health Risk Manag; 2014; 10():477-91. PubMed ID: 25143742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriate secondary prevention and clinical outcomes after acute myocardial infarction according to atherothrombotic risk stratification: The FAST-MI 2010 registry.
    Tea V; Bonaca M; Chamandi C; Iliou MC; Lhermusier T; Aissaoui N; Cayla G; Angoulvant D; Ferrières J; Schiele F; Simon T; Danchin N; Puymirat E;
    Eur J Prev Cardiol; 2019 Mar; 26(4):411-419. PubMed ID: 30354737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Outcomes with or without Beta-Blocker Therapy After Acute Myocardial Infarction in Patients Without Heart Failure or Left Ventricular Systolic Dysfunction (from the Acute Coronary Syndromes Israeli Survey [ACSIS]).
    El Nasasra A; Beigel R; Klempfner R; Alnsasra H; Matetzky S; Iakobishvili Z; Rubinshtein R; Halabi M; Blatt A; Zahger D
    Am J Cardiol; 2021 Mar; 143():1-6. PubMed ID: 33359228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Oral Beta-Blockers and Clinical Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: a Long-Term Follow-Up Study.
    Nicolau JC; Furtado RHM; Baracioli LM; Lara LM; Dalçóquio TF; Scanavini Junior MA; Pereira CAC; Lima VM; Gonçalves TM; Colodetti R; Ferrari AG; Lopes RD; Giugliano RP
    Cardiovasc Drugs Ther; 2018 Oct; 32(5):435-442. PubMed ID: 30128818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE).
    Park KL; Goldberg RJ; Anderson FA; López-Sendón J; Montalescot G; Brieger D; Eagle KA; Wyman A; Gore JM;
    Am J Med; 2014 Jun; 127(6):503-11. PubMed ID: 24561113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of β-blocker in ST-segment elevation myocardial infarction in patients with preserved left ventricular systolic function: a propensity analysis.
    Konishi H; Miyauchi K; Kasai T; Tsuboi S; Ogita M; Naito R; Nishizaki Y; Okai I; Tamura H; Okazaki S; Isoda K; Daida H
    Heart Vessels; 2016 Apr; 31(4):441-8. PubMed ID: 25573259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes and Prognostic Impact of Prophylactic Oral Anticoagulation in Anterior ST-Segment Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction.
    Shavadia JS; Youngson E; Bainey KR; Bakal J; Welsh RC
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study.
    Munkhaugen J; Ruddox V; Halvorsen S; Dammen T; Fagerland MW; Hernæs KH; Vethe NT; Prescott E; Jensen SE; Rødevand O; Jortveit J; Bendz B; Schirmer H; Køber L; Bøtker HE; Larsen AI; Vikenes K; Steigen T; Wiseth R; Pedersen T; Edvardsen T; Otterstad JE; Atar D
    Am Heart J; 2019 Feb; 208():37-46. PubMed ID: 30530121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis.
    Ruddox V; Sandven I; Munkhaugen J; Skattebu J; Edvardsen T; Otterstad JE
    Eur J Prev Cardiol; 2017 Sep; 24(14):1555-1566. PubMed ID: 28617620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum potassium levels and mortality of patients with acute myocardial infarction: A systematic review and meta-analysis of cohort studies.
    Xi H; Yu RH; Wang N; Chen XZ; Zhang WC; Hong T
    Eur J Prev Cardiol; 2019 Jan; 26(2):145-156. PubMed ID: 31060369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.